Challenges and opportunities with glycogen synthase kinase-3 inhibitors for insulin resistance and Type 2 diabetes treatment (Q35207622)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q59621476)
(P304) 1511-1519
(P407) (Q1860)
(P433) 9
(P478) 12
(P577) Monday, September 1, 2003
(P921) (Q3025883)
(Q1053470)
(P1433) (Q5421208)
(P1476) "Challenges and opportunities with glycogen synthase kinase-3 inhibitors for insulin resistance and Type 2 diabetes treatment" (language: en)
(P2093) Ronit Ilouz
(P2860) (Q33588931)
(Q34534983)
(Q41437636)
(Q42811852)
(Q36573174)
(Q29619774)
(Q41743578)
(Q48829897)
(Q29620489)
(Q34552674)
(Q27860731)
(Q27632797)
(Q27633064)
(Q52569765)
(Q40768816)
(Q24312910)
(Q28640539)
(Q29614380)
(Q50319772)
(Q29620188)
(Q28115262)
(Q40900540)
(Q29616320)
(Q46166465)
(Q28344791)
(Q34669625)
(Q33716092)
(Q33716108)
(Q34792879)
(Q34179931)
(Q31462537)
(Q33596950)
(Q24629067)
(Q31855623)
(Q42485992)
(Q43858813)
(Q40722427)
(Q29620190)
(Q33945272)
(Q44406427)
(Q42522942)
(Q44155466)
(Q30732148)
(Q43907791)
(Q34905149)
(Q33533847)
(Q34319274)
(Q34323681)
(Q44209151)
(Q28140761)
(Q37735190)
(Q57833221)
(P13046) (Q7318358)
other details
description scientific article

External Links